Why the study?
Does pindolol improve hemodynamic parameters in patients with essential hypertension?
Does pindolol improve hemodynamic parameters in patients with essential hypertension?
Pindolol lowers blood pressure in essential hypertension through negative chronotropic effects, decreased peripheral resistance, and increased vascular capacitance.
Pindolol may improve hemodynamics in essential hypertension; hypothesis-generating and should not yet change practice.
Ten patients, mean age 48 years, with essential hypertension of stage I and II according to the WHO classification, have been studied at rest and during work before and after on average 8 weeks oral treatment with a beta-adrenergic blocking agent, pindolol. The pindolol treatment caused a significant decrease in the systemic systolic and diastolic blood pressure, heart rate and cardiac output both at rest and during work. The systemic vascular resistance and the forearm vascular resistance decreased significantly after and during work, respectively. Forearm venous tone was significantly decreased at rest, during and after work. The plasma renin activity decreased. Three mechanisms seem to be involved in the antihypertensive effect of pindolol: 1) a negative chronotropic effect on the heart, 2) a decrease in peripheral vascular resistance, and 3) an increase in vascular capacitance affecting the venous return.
No takes yet. Share an insight, caveat, or question.
Atterhög et al. (1976) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: